Kim DD - Search Results

1

In-vitro and in-vivo antibacterial activity evaluation of a polyurethane matrix.

Lee SH, Kim SR, Kim JS, Bae HR, Lee CH, Kim DD. Lee SH, et al. Among authors: kim sr, kim dd, kim js. J Pharm Pharmacol. 2003 Apr;55(4):559-66. doi: 10.1211/002235702883. J Pharm Pharmacol. 2003. PMID: 12803779

2

Physicochemical properties of CWJ-a-5, a new antitumor 3-arylisoquinoline derivative.

Kim KE, Cho WJ, Kim TS, Kang BH, Chang SJ, Lee CH, Kim DD. Kim KE, et al. Among authors: kim ts, kim dd. Drug Dev Ind Pharm. 2002 Aug;28(7):889-95. doi: 10.1081/ddc-120005634. Drug Dev Ind Pharm. 2002. PMID: 12236074

3

The effects of pressure-sensitive adhesives and solubilizers on the skin permeation of testosterone from a matrix-type transdermal delivery system.

Zhao H, Park DW, Kim SK, Lee CH, Kim DD. Zhao H, et al. Among authors: kim dd, kim sk. Drug Dev Ind Pharm. 2002 Oct;28(9):1125-31. doi: 10.1081/ddc-120014579. Drug Dev Ind Pharm. 2002. PMID: 12455471

4

In vitro evaluation of patch formulations for topical delivery of gentisic acid in rats.

Bian S, Doh HJ, Zheng J, Kim JS, Lee CH, Kim DD. Bian S, et al. Among authors: kim dd, kim js. Eur J Pharm Sci. 2003 Feb;18(2):141-7. doi: 10.1016/s0928-0987(02)00255-5. Eur J Pharm Sci. 2003. PMID: 12594007

5

Development of a novel soft hydrogel for the transdermal delivery of testosterone.

An NM, Kim DD, Shin YH, Lee CH. An NM, et al. Among authors: kim dd. Drug Dev Ind Pharm. 2003 Jan;29(1):99-105. doi: 10.1081/ddc-120016688. Drug Dev Ind Pharm. 2003. PMID: 12602497

6

Synthesis and evaluation of Ketorolac ester prodrugs for transdermal delivery.

Doh HJ, Cho WJ, Yong CS, Choi HG, Kim JS, Lee CH, Kim DD. Doh HJ, et al. Among authors: kim dd, kim js. J Pharm Sci. 2003 May;92(5):1008-17. doi: 10.1002/jps.10353. J Pharm Sci. 2003. PMID: 12712420

7

Serially passaged human nasal epithelial cell monolayer for in vitro drug transport studies.

Yoo JW, Kim YS, Lee SH, Lee MK, Roh HJ, Jhun BH, Lee CH, Kim DD. Yoo JW, et al. Among authors: kim dd, kim ys. Pharm Res. 2003 Oct;20(10):1690-6. doi: 10.1023/a:1026112107100. Pharm Res. 2003. PMID: 14620527

8

Effects of HPE-101, a skin penetration enhancer, on human erythrocyte membranes.

Lee KJ, Hwang SJ, Kim JS, Kim DD, Shin YH, Lee CH. Lee KJ, et al. Among authors: kim dd, kim js. Int J Pharm. 2004 Nov 5;285(1-2):43-9. doi: 10.1016/j.ijpharm.2004.07.022. Int J Pharm. 2004. PMID: 15488678

9

Evaluation of the physicochemical stability and skin permeation of glucosamine sulfate.

Kanwischer M, Kim SY, Kim JS, Bian S, Kwon KA, Kim DD. Kanwischer M, et al. Among authors: kim dd, kim sy, kim js. Drug Dev Ind Pharm. 2005 Jan;31(1):91-7. doi: 10.1081/ddc-44181. Drug Dev Ind Pharm. 2005. PMID: 15704860

10

Ketorolac amide prodrugs for transdermal delivery: stability and in vitro rat skin permeation studies.

Kim BY, Doh HJ, Le TN, Cho WJ, Yong CS, Choi HG, Kim JS, Lee CH, Kim DD. Kim BY, et al. Among authors: kim dd, kim js. Int J Pharm. 2005 Apr 11;293(1-2):193-202. doi: 10.1016/j.ijpharm.2005.01.002. Int J Pharm. 2005. PMID: 15778057

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,086 results

Search Page

Filters